32 results
8-K
EX-1.1
17i g9zi30vs7ujn
15 Nov 23
Entry into a Material Definitive Agreement
5:02pm
8-K
EX-99.1
fyz5pt9h
14 Nov 23
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2023 Results and Provides Business Update
4:05pm
8-K
EX-99.1
r319f8ey
3 Nov 23
Acurx Announces Positive Top-Line Ibezapolstat Phase 2 Efficacy Results with 96% Clinical Cure Rate in Patients with C. difficile Infection
4:05pm
8-K
EX-99.1
1mo5tto65o1rkf
2 Oct 23
Other Events
4:41pm
8-K
EX-99.1
t8bbu5se 6l
14 Aug 23
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2023 Results and Provides Business Update
7:10am
8-K
EX-10.1
uvlpxg
17 May 23
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
4:19pm
8-K
EX-10.1
trnk0o5p0
25 Jul 22
Acurx Pharmaceuticals, Inc. Announces $4.225 Million Registered Direct Offering
8:46am
8-K
EX-99.1
wrurag7mlg
11 May 22
Acurx Pharmaceuticals, Inc. Reports First Quarter 2022 Results and Provides Business Update
7:11am